FDA is issuing an updated alert that Reumofan Plus and Reumofan Plus
Premium contain undeclared active ingredients found in prescription
drugs that should be used only under the supervision of a health care
professional.
Since June 1, 2012, when FDA first warned the
public about the dangers of these supplements, the agency has received
reports of fatalities, stroke, severe bleeding in the gastrointestinal
tract (including the esophagus, stomach and intestines), dizziness,
insomnia (difficulty sleeping), high blood sugar levels and problems
with liver and kidney functions, as well as corticosteroid withdrawal
syndrome.
Read more....
No comments:
Post a Comment